APA (7th ed.) Citation

Fang, L., Zheng, Z., & Cai, H. First-line treatment with durvalumab plus chemotherapy versus chemotherapy alone for metastatic non-small-cell lung cancer in the USA: A cost-effectiveness analysis. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Fang, Ling, Zhiwei Zheng, and Hongfu Cai. First-line Treatment with Durvalumab Plus Chemotherapy Versus Chemotherapy Alone for Metastatic Non-small-cell Lung Cancer in the USA: A Cost-effectiveness Analysis. BMJ Publishing Group.

MLA (9th ed.) Citation

Fang, Ling, et al. First-line Treatment with Durvalumab Plus Chemotherapy Versus Chemotherapy Alone for Metastatic Non-small-cell Lung Cancer in the USA: A Cost-effectiveness Analysis. BMJ Publishing Group.